Reinsurance Group of America is in an unusual spot: shorts have largely left the building after a strong Q2 print, yet options traders are still buying protection at one of the more elevated rates seen all year.
The analyst response to Q2 has been unambiguous. JP Morgan lifted its target to $293 from $286 just this week, maintaining Overweight — a second raise in three weeks from the same desk. Barclays was first to respond post-earnings on August 7, pushing to $290 from $278, also Overweight. Every name that moved in July and again after the print raised rather than cut, and consensus now sits at $266.89 against a stock at $244.65 — roughly 9% implied upside. TD Cowen remains the only meaningful dissenter, holding a Hold with a $235 target that sits below the current price, anchoring the bear count without adding urgency. The Street's direction of travel is clearly constructive, and it has been consistent across the entire pre- and post-earnings window.
The short positioning story is equally clean — shorts are gone. Short interest fell 31% in a week to 1.22% of free float, the lowest level in the available 30-day history. Borrow conditions back that up: availability is effectively uncapped, with 64.8 million shares available to lend against fewer than 805,000 actually borrowed, and cost to borrow rests at 0.45% — negligible by any measure. There is no squeeze dynamic, no friction, no sign of remaining conviction on the short side. The post-earnings capitulation appears complete.
What complicates the clean bull narrative is options. Put demand has risen sharply, with the put/call ratio at 0.42 — nearly two standard deviations above its 20-day mean of 0.19. For context, RGA's PCR spent most of July below 0.10, then stepped up into earnings and has remained elevated since the print. That is unusual behaviour for a stock that just rallied 4.2% on its earnings day and another 3.6% over the past week. The options market is not celebrating the way the tape would suggest it should. Whether this reflects hedging by long holders who rode the rally or fresh scepticism about the next leg is the open question this week.
Peer performance reinforces RGA's relative strength. EG slipped 0.95% on the week. AFL fell 3.3%. PFG dropped nearly 2%. PRU was marginally lower. RGA's 3.6% weekly gain stands out sharply against a peer group that broadly moved in the opposite direction, suggesting the earnings beat drew real rotation rather than sector-wide tailwinds. Institutional ownership data supports steady long-side engagement: BlackRock holds 10.4% and added 131,000 shares through July, while Fidelity carries 8.9% and added 122,000 shares. Harris Associates holds a further 7.4%, though that position was last updated in March.
The next earnings event is scheduled for November 5. Between now and then, what's worth watching is whether that elevated options skew resolves back toward the low-single-digit PCR readings that defined most of July — and whether JP Morgan's fresh $293 target, now the highest on the Street, attracts any competing upgrades to close the gap with consensus.
See the live data behind this article on ORTEX.
Open RGA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
